Noelia Nebot

725 total citations
17 papers, 432 citations indexed

About

Noelia Nebot is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Noelia Nebot has authored 17 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 4 papers in Neurology. Recurrent topics in Noelia Nebot's work include Melanoma and MAPK Pathways (8 papers), Neuroblastoma Research and Treatments (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Noelia Nebot is often cited by papers focused on Melanoma and MAPK Pathways (8 papers), Neuroblastoma Research and Treatments (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Noelia Nebot collaborates with scholars based in United States, United Kingdom and Australia. Noelia Nebot's co-authors include Michael T. Murray, Séverine Crettol, Bruce N. Tattam, David E. Hibbs, Stanley W. Carson, Alberto Broniscer, James A. Whitlock, Mark W. Russo, Pooja Hingorani and Birgit Geoerger and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Noelia Nebot

17 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Noelia Nebot United States	11	180	164	94	62	55	17	432
Rebecca R. Thomas United States	10	253 1.4×	562 3.4×	52 0.6×	110 1.8×	100 1.8×	10	897
Mukul Minocha United States	13	151 0.8×	256 1.6×	56 0.6×	84 1.4×	45 0.8×	32	612
Michela Guardascione Italy	16	331 1.8×	336 2.0×	80 0.9×	195 3.1×	45 0.8×	37	847
Hans-Peter Gschwind Switzerland	10	181 1.0×	97 0.6×	105 1.1×	52 0.8×	148 2.7×	15	466
Jean-Pierre Bizzari France	14	288 1.6×	267 1.6×	73 0.8×	95 1.5×	20 0.4×	24	515
Yi Ling Teo Singapore	9	228 1.3×	262 1.6×	57 0.6×	130 2.1×	80 1.5×	11	625
Rempei Yanagawa Japan	7	328 1.8×	180 1.1×	26 0.3×	45 0.7×	30 0.5×	8	537
Steffanie L. Furtek United States	4	239 1.3×	256 1.6×	43 0.5×	42 0.7×	37 0.7×	4	480
Maura A. Kraynak United States	13	308 1.7×	431 2.6×	50 0.5×	153 2.5×	39 0.7×	19	807
Herbert Birnboeck Switzerland	9	115 0.6×	162 1.0×	56 0.6×	244 3.9×	38 0.7×	11	654

Countries citing papers authored by Noelia Nebot

Since Specialization

Citations

This map shows the geographic impact of Noelia Nebot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noelia Nebot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noelia Nebot more than expected).

Fields of papers citing papers by Noelia Nebot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noelia Nebot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noelia Nebot. The network helps show where Noelia Nebot may publish in the future.

Co-authorship network of co-authors of Noelia Nebot

This figure shows the co-authorship network connecting the top 25 collaborators of Noelia Nebot. A scholar is included among the top collaborators of Noelia Nebot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noelia Nebot. Noelia Nebot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Nebot, Noelia, et al.. (2021). Evaluation of the Effects of Repeat‐Dose Dabrafenib on the Single‐Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate). Clinical Pharmacology in Drug Development. 10(9). 1054–1063. 4 indexed citations

Kieran, Mark W., Birgit Geoerger, Ira J. Dunkel, et al.. (2019). A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation–Positive Solid Tumors. Clinical Cancer Research. 25(24). 7294–7302. 58 indexed citations

Mak, Gabriel, Jean‐Charles Soria, Sarah P. Blagden, et al.. (2019). A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours. British Journal of Cancer. 120(10). 975–981. 69 indexed citations

Tran‐Dinh, Alexy, Marlène Amara, Noelia Nebot, et al.. (2018). Impact of intensive care unit relocation and role of tap water on an outbreak of Pseudomonas aeruginosa expressing OprD-mediated resistance to imipenem. Journal of Hospital Infection. 100(3). e105–e114. 10 indexed citations

Geoerger, Birgit, Christopher L. Moertel, James A. Whitlock, et al.. (2018). Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN).. Journal of Clinical Oncology. 36(15_suppl). 10537–10537. 18 indexed citations

Kieran, Mark W., Éric Bouffet, Alberto Broniscer, et al.. (2018). Efficacy and safety results from a phase I/IIa study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed refractory low-grade glioma.. Journal of Clinical Oncology. 36(15_suppl). 10506–10506. 14 indexed citations

Nebot, Noelia, Hendrik‐Tobias Arkenau, Jeffrey R. Infante, et al.. (2017). Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with BRAF V600–mutant tumours. British Journal of Clinical Pharmacology. 84(4). 764–775. 12 indexed citations

Kieran, Mark W., Éric Bouffet, Uri Tabori, et al.. (2016). CNS tumours The first study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed or refractory low-grade gliomas. Annals of Oncology. 27. vi557–vi557. 13 indexed citations

Nebot, Noelia, H-T. Arkenau, Jeffrey R. Infante, et al.. (2016). Evaluation of the effect of dabrafenib on QTc interval in patients with BRAF V600–mutant tumors.. Journal of Clinical Oncology. 34(15_suppl). e14119–e14119. 1 indexed citations

10.

Arkenau, Hendrik‐Tobias, Anas Gazzah, Ruth Plummer, et al.. (2015). A phase Ib dose-escalation study of GSK2256098 (FAKi) plus trametinib (MEKi) in patients with selected advanced solid tumors.. Journal of Clinical Oncology. 33(15_suppl). 2593–2593. 4 indexed citations

11.

Swift, Brandon, Noelia Nebot, Jin Kyung Lee, et al.. (2013). Sorafenib Hepatobiliary Disposition: Mechanisms of Hepatic Uptake and Disposition of Generated Metabolites. Drug Metabolism and Disposition. 41(6). 1179–1186. 52 indexed citations

12.

Ouellet, Danièle, Kenneth F. Grossmann, Noelia Nebot, et al.. (2013). Effects of particle size, food, and capsule shell composition on the oral bioavailability of dabrafenib, a BRAF inhibitor, in patients with BRAF mutation-positive tumors. Journal of Pharmaceutical Sciences. 102(9). 3100–3109. 40 indexed citations

13.

Ouellet, Danièle, Noelia Nebot, Stanley W. Carson, et al.. (2013). Metabolism and Disposition of Oral Dabrafenib in Cancer Patients: Proposed Participation of Aryl Nitrogen in Carbon-Carbon Bond Cleavage via Decarboxylation following Enzymatic Oxidation. Drug Metabolism and Disposition. 41(12). 2215–2224. 36 indexed citations

14.

Gan, Hui, Noelia Nebot, J.C. Soria, et al.. (2012). 613 Pharmacokinetics/pharmacodynamics (PK/PD) of GSK2256098, a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with Advanced Solid Tumors. European Journal of Cancer. 48. 189–189. 3 indexed citations

15.

Soria, Jean‐Charles, Hui Gan, Hendrik‐Tobias Arkenau, et al.. (2012). Phase I clinical and pharmacologic study of the focal adhesion kinase (FAK) inhibitor GSK2256098 in pts with advanced solid tumors.. Journal of Clinical Oncology. 30(15_suppl). 3000–3000. 12 indexed citations

16.

Nebot, Noelia, et al.. (2010). Participation of CYP2C8 and CYP3A4 in the N‐demethylation of imatinib in human hepatic microsomes. British Journal of Pharmacology. 161(5). 1059–1069. 76 indexed citations

17.

Nebot, Noelia, et al.. (2010). Impaired irinotecan biotransformation in hepatic microsomal fractions from patients with chronic liver disease. British Journal of Clinical Pharmacology. 70(3). 400–408. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact